Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This trial compares trabectedin alone to trabectedin in combination with regional
hyperthermia in patients with high-risk soft tissue sarcoma. The study is designed to
demonstrate a significant benefit for sarcoma-therapy by adding regional hyperthermia.